James B. Ray
@rxpalli8r.bsky.social
Palliative care pharmacist teaching goal-concordant pharmacotherapy in serious illness | fortunate husband | appreciative Band Dad
https://pharmacy.uiowa.edu/departments/Pharmacy_Practice_Science/SOLACE
https://pharmacy.uiowa.edu/departments/Pharmacy_Practice_Science/SOLACE
Shortages coupled with the DEA again limiting the manufacturing quota for opioids for the 10th consecutive year - www.painnewsnetwork.org/stories/2025...
DEA Plans Further Cuts in Oxycodone Supply — Pain News Network
By Pat Anson The Drug Enforcement Administration is planning to cut the supply of oxycodone by over 6% in 2026, along with marginal reductions in the supply of hydrocodone, morphine and other Schedul...
www.painnewsnetwork.org
December 4, 2025 at 1:10 AM
Shortages coupled with the DEA again limiting the manufacturing quota for opioids for the 10th consecutive year - www.painnewsnetwork.org/stories/2025...
You are modeling memento mori - which seems so healthy given the current state of affairs in this country.
December 2, 2025 at 2:19 AM
You are modeling memento mori - which seems so healthy given the current state of affairs in this country.
It would be great to have 2B6 isoenzyme as a part of any P-450 panels to determine polymorphisms (S-isomer pathway and risk for cardiotoxicity). This would enhance the safe use of the methadone in HAPC.
December 1, 2025 at 7:55 PM
It would be great to have 2B6 isoenzyme as a part of any P-450 panels to determine polymorphisms (S-isomer pathway and risk for cardiotoxicity). This would enhance the safe use of the methadone in HAPC.
Hopefully, with affordable genomic panels that will be covered by insurance. It would certainly reduce a lot of therapeutic blind alleys and the need for "time-limited" trials to determine efficacy/tolerability.
December 1, 2025 at 7:55 PM
Hopefully, with affordable genomic panels that will be covered by insurance. It would certainly reduce a lot of therapeutic blind alleys and the need for "time-limited" trials to determine efficacy/tolerability.
Where are his hearing aids? With the benefits they all receive, would you think he would have the top of the line. Not to mention that hearing loss is a modifiable risk factor for dementia!
October 29, 2025 at 7:46 PM
Where are his hearing aids? With the benefits they all receive, would you think he would have the top of the line. Not to mention that hearing loss is a modifiable risk factor for dementia!
Ok, just be careful how you schedule the Q6 so your patient isn’t receiving at 0200 each night. Interrupting sleep for meds = risk for inpatient delirium.
October 9, 2025 at 5:36 PM
Ok, just be careful how you schedule the Q6 so your patient isn’t receiving at 0200 each night. Interrupting sleep for meds = risk for inpatient delirium.